NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.20
arrow_downward
-0.73%(-0.0015) 1D
Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NWBO...
Open
$0.20
High
$0.21
Low
$0.20
Mkt. cap
334.42M
Avg. vol.
3.93M
Volume
1.93M
52-wk high
$0.37
52-wk low
$0.18
EPS
-$0.03
Beta
-0.67
Shares outstanding
1.64B
No. of employees
105
Open
$0.20
High
$0.21
Low
$0.20
Mkt. cap
334.42M
Avg. vol.
3.93M
Volume
1.93M
52-wk high
$0.37
52-wk low
$0.18
EPS
-$0.03
Beta
-0.67
Shares outstanding
1.64B
No. of employees
105
News stories
From sources across the web
IndexBox
·
1 hour ago
Jindalee Lithium Plans Nasdaq Listing for US Elemental via SPAC Merger in H2 2026 - News and Statistics
Foreign Policy Journal
·
10 minutes ago
Strong Jobs Report Sends Nvidia (NASDAQ: NVDA), Intel (NASDAQ: INTC), Marvell (NASDAQ: MRVL) And Other AI Stocks Tumbling
Yahoo Finance
·
1 hour ago
1 Costly Mistake Too Many Investors Make With the Vanguard S&P 500 ETF (VOO)
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
AI content may include mistakes. Learn more